IP Verse

Rb Pharmaceuticals competitive analysis

Latest publications and patents of Rb Pharmaceuticals New

Explore the latest publications and patents granted to Rb Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Rb Pharmaceuticals
EP2579874	Jan 10, 2018	Injectable Flowable Composition Comprising Buprenorphine	Opposition Rejected

Latest patents of Rb Pharmaceuticals opposed by its competitors

Explore Rb Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2579874	Jan 10, 2018	Injectable Flowable Composition Comprising Buprenorphine	1

Latest PTAB cases involving Rb Pharmaceuticals

Discover the latest PTAB cases involving Rb Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Rb Pharmaceuticals
IPR2014-00998	Jun 20, 2014	BIODELIVERY SCIENCES	RB PHARMACEUTICALS	Institution Denied
IPR2014-00325	Jan 15, 2014	BIODELIVERY SCIENCES	RB PHARMACEUTICALS	Final Written Decision

Peer Comparison New

IP litigation analysis comparing Rb Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
RB PHARMACEUTICALS	-	1	-	2	Non-Active
BIODELIVERY SCIENCES	-	-	9	-	Highly Aggressive
TEVA PHARMACEUTICALS	205	15	-	12	Highly Aggressive